190 related articles for article (PubMed ID: 2821617)
61. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen.
Garvin AM; Abraham KM; Forbush KA; Farr AG; Davison BL; Perlmutter RM
Int Immunol; 1990; 2(2):173-80. PubMed ID: 1965144
[TBL] [Abstract][Full Text] [Related]
62. T cells are responsive to the simian virus 40 large tumor antigen transgenically expressed in pancreatic islets.
Geiger T; Soldevila G; Flavell RA
J Immunol; 1993 Dec; 151(12):7030-7. PubMed ID: 8258707
[TBL] [Abstract][Full Text] [Related]
63. A genetically engineered mouse model developing rapid progressive pancreatic ductal adenocarcinoma.
Yamaguchi T; Ikehara S; Nakanishi H; Ikehara Y
J Pathol; 2014 Oct; 234(2):228-38. PubMed ID: 25042889
[TBL] [Abstract][Full Text] [Related]
64. Gonadal tumorigenesis in transgenic mice bearing the mouse inhibin alpha-subunit promoter/simian virus T-antigen fusion gene: characterization of ovarian tumors and establishment of gonadotropin-responsive granulosa cell lines.
Kananen K; Markkula M; Rainio E; Su JG; Hsueh AJ; Huhtaniemi IT
Mol Endocrinol; 1995 May; 9(5):616-27. PubMed ID: 7565808
[TBL] [Abstract][Full Text] [Related]
65. Hepatocarcinogenesis in transgenic mice carrying albumin-promoted SV40 T antigen gene.
Hino O; Kitagawa T; Nomura K; Ohtake K; Cui L; Furuta Y; Aizawa S
Jpn J Cancer Res; 1991 Nov; 82(11):1226-33. PubMed ID: 1684356
[TBL] [Abstract][Full Text] [Related]
66. Impact of the genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas.
Cho HJ; Seiberg M; Georgoff I; Teresky AK; Marks JR; Levine AJ
J Neurosci Res; 1989 Sep; 24(1):115-22. PubMed ID: 2478718
[TBL] [Abstract][Full Text] [Related]
67. Subcutaneous sarcomas of probable neuronal origin in a transgenic mouse strain containing an albumin promoter-fused simian virus 40 large T antigen gene.
Kawabuchi B; Nomura K; Ohtake K; Hino O; Aizawa S; Machinami R; Kitagawa T
Jpn J Cancer Res; 1994 Jun; 85(6):601-9. PubMed ID: 8063613
[TBL] [Abstract][Full Text] [Related]
68. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
69. Selective expression of trypsin fusion genes in acinar cells of the pancreas and stomach of transgenic mice.
Davis BP; Hammer RE; Messing A; MacDonald RJ
J Biol Chem; 1992 Dec; 267(36):26070-7. PubMed ID: 1464618
[TBL] [Abstract][Full Text] [Related]
70. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen.
Ewald D; Li M; Efrat S; Auer G; Wall RJ; Furth PA; Hennighausen L
Science; 1996 Sep; 273(5280):1384-6. PubMed ID: 8703072
[TBL] [Abstract][Full Text] [Related]
71. Immortalized retinal neurons derived from SV40 T-antigen-induced tumors in transgenic mice.
Hammang JP; Baetge EE; Behringer RR; Brinster RL; Palmiter RD; Messing A
Neuron; 1990 May; 4(5):775-82. PubMed ID: 2344410
[TBL] [Abstract][Full Text] [Related]
72. Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors.
Du YC; Klimstra DS; Varmus H
PLoS One; 2009 Sep; 4(9):e6932. PubMed ID: 19812721
[TBL] [Abstract][Full Text] [Related]
73. Mice transgenic with SV40-late-promoter-driven Polyomavirus Middle T oncogene exclusively develop hemangiomas.
Xu Q; Chen W; Wang Z; Zheng J; Zhang Z
Transgenic Res; 2009 Jun; 18(3):399-406. PubMed ID: 19067215
[TBL] [Abstract][Full Text] [Related]
74. Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice.
Dubois N; Bennoun M; Allemand I; Molina T; Grimber G; Daudet-Monsac M; Abelanet R; Briand P
J Hepatol; 1991 Sep; 13(2):227-39. PubMed ID: 1660504
[TBL] [Abstract][Full Text] [Related]
75. Tissue-specific expression of the rat pancreatic elastase I gene in transgenic mice.
Swift GH; Hammer RE; MacDonald RJ; Brinster RL
Cell; 1984 Oct; 38(3):639-46. PubMed ID: 6567483
[TBL] [Abstract][Full Text] [Related]
76. Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors.
Gallo-Hendrikx E; Percy D; Copps J; McKeown B; Quinton M; McMillan I; Croy BA; Wildeman AG
APMIS; 1999 Feb; 107(2):245-56. PubMed ID: 10225324
[TBL] [Abstract][Full Text] [Related]
77. Abnormal differentiation, hyperplasia and embryonic/perinatal lethality in BK5-T/t transgenic mice.
Chen X; Schneider-Broussard R; Hollowell D; McArthur M; Jeter CR; Benavides F; DiGiovanni J; Tang DG
Differentiation; 2009 Mar; 77(3):324-34. PubMed ID: 19272531
[TBL] [Abstract][Full Text] [Related]
78. Angiogenesis in transgenic models of multistep carcinogenesis.
D' Angelo MG; Afanasieva T; Aguzzi A
J Neurooncol; 2000; 50(1-2):89-98. PubMed ID: 11245284
[TBL] [Abstract][Full Text] [Related]
79. Expression of the pancreatic elastase I gene in transgenic mice.
MacDonald RJ
Hepatology; 1987; 7(1 Suppl):42S-51S. PubMed ID: 3542783
[No Abstract] [Full Text] [Related]
80. Transgenic mouse models and peptide producing endocrine tumours: morpho-functional aspects.
Rindi G; Solcia E; Polak JM
Experientia Suppl; 1989; 56():210-9. PubMed ID: 2522889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
